Synthetic lethality--a new direction in cancer-drug development.

  title={Synthetic lethality--a new direction in cancer-drug development.},
  author={James Dirk Iglehart and Daniel P. Silver},
  journal={The New England journal of medicine},
  volume={361 2},
In this issue of the Journal, Fong et al. report the results of a phase 1 trial of a new cancer therapy involving 60 patients ( number, NCT00516373).1 Readers may be surprised by the editors’ decision to publish a small early-stage trial, but this trial not only reports important results — it also points to a new direction in the development of anticancer drugs. Modern cancerdrug discovery focuses on finding new therapies with few side effects by leveraging advances in the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
76 Citations
13 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 76 extracted citations

Journal Club

  • Multiples Myelom
  • Medizinische Klinik
  • 2009
Highly Influenced
5 Excerpts


Publications referenced by this paper.
Showing 1-10 of 13 references

Similar Papers

Loading similar papers…